Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells

Inclusion Criteria

• •1. 18-65 years old, regardless of sex;
• •2. Patients with lymphoma and multiple myeloma who need autologous hematopoietic stem cell transplantation;
• •3. KPS score ≥70;
• •4. creatinine clearance rate ≥ 50mL/min, total bilirubin level \< 1.5mg/dL, ALT and AST \< 2 times the upper limit of normal value;
• •5. Absolute neutrophil count (ANC)≥1.5×109/L, platelet count ≥80×109/L, Hb≥ 75g/L, WBC ≥ 3.0× 109/L;
• •6. Patients can tolerate chemotherapy;
• •7. No active infection before chemotherapy;
• •8. The patient voluntarily participated in this trial and signed the informed consent form;
• •9. The researcher thinks that the subjects can benefit.